Twist Bioscience

TWST

$
30.93
(
-3.7
%)
(
+
-3.7
%)
+
18.8
%
36.74
NASDAQ

Last Price

12/12/25, 09:30 AM
 EDT

Margin of Safety

Current Compounder
$
36.74

PORTFOLIO CATEGORY

Modeled fair value

Up to 5%
$2.260 billion

Allocation Suggestion

Modeled fair value

Model Basis

LAST REFINED:
June 18, 2025
The current model INCLUDES the following assets and assumptions:
The current model is based on operating metrics, including:
  • Component A: Full-year 2025 revenue of $400.733 million
The current model EXCLUDES the following assets:
  • Licensing deals for antibody drug candidates discovered with Twist's technology platform and/or libraries
  • DNA data storage initiatives

Research Deep Dive

Last Updated:

Overview

Solt DB Invest will introduce Base Research for our coverage ecosystem over the next month to coincide with third-quarter 2023 earnings announcements. Check back soon!

Technology Platform

Pipeline

Portfolio

Opportunities & Advantages

Challenges & Risks

Development Risk 

Regulatory Risk 

Commercial Risk 

Dilution Risk 

Valuation Risk 

Geopolitical Risk 

Unique Risks 

Modeling Insights

News Flow & Timing